Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Your Budget Mounjaros ability to target both GLP-1 and GIP pathways, comes at a higher cost (varying from 30% 100% higher than Ozempic)
Colleen McCabe, PharmD, BCOP, and Lindsay Mundy, PharmD, BCOP, led an engaging exploration of the benefits and potential pitfalls with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in an oncology setting in their presentation, GLP-1s in Oncology: Miracle, Misdirection, or Missed Opportunity
1,2 Individual responses vary considerably
patients must meet qualifying criteria set through negotiations This is the largest potential expansion of obesity drug access in Medicaid history but its not automatic
US$ 24.39
US$ 29.74
US$ 23.43
US$ 26.09
US$ 21.79
US$ 21.53
US$ 25.38
US$ 20.12
US$ 26.54
US$ 23.77
US$ 25.68
